Search Results 811-820 of 108875 for b-

  1. Meet Our Fellows - Cardiovascular Diseases Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Muhannad Abbasi, M.B., B.Ch. · Fadi Adel, M.D. · Abdullah Al-Abcha, M.D. · Viral Desai, M.B.B.S. · Teodora Donisan, M.D. · Edward El-Am, M.D. · David Harmon, Jr., ...

  2. Publications - Courtney E. Bennett, D.O. - Mayo Clinic

    Publications. Print. Senman B, Sinha SS, Truesdell AG, Safiriyu I, Drakos S, Dupont AG, Basir MB, Miller PE, Rali AS, Bennett C, Tehrani B, Cowger J, Hall SA ...

  3. Publications - Tuhama S. Rihani, M.D. - Mayo Clinic

    Publications · Mansour MM, Seby RM, Elalfy A, El Hayek M, Rihani TS, Mwakyanjala EJ, Rueda Prada L. · Ernst AA, Weiss SJ, Morgan-Edwards S, Rihani T, Coffman B, ...

  4. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

    The purpose of this study is to determine the maximum tolerated dose of this drug (MEDI-551) in subjects with advanced B-cell malignancies. Expansion to occur ...

  5. Measles - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    The Vaccine Research Group at Mayo Clinic is researching measles to better understand the virus and develop effective vaccines.

  6. Interferon beta-1b (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Description. Interferon beta-1b injection is used to treat the relapsing-remitting forms of multiple sclerosis (MS), including clinically isolated syndrome, ...

  7. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) · Share · Facebook ...

  8. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell NHL after failure of rituximab and anthracycline containing frontline immunochemotherapy. Participation eligibility. Participant eligibility includes ...

  9. Mayo Clinic remembers Dr. Michael O'Sullivan, former member of Board of Governors, pioneering leader

    Michael B. O'Sullivan was born Aug. 20, 1935, in Tralee, County Kerry, Ireland. He received his medical degree from University College, Cork, Ireland, and ...

  10. Publications - John C. Schupbach, M.D., M.B.A. - Mayo Clinic

    ... B, Mullan A, Cabrera D. FDA-reviewed artificial intelligence-enabled products applicable to emergency medicine. Am J Emerg Med. 2025 Mar; 89:241-246 Epub ...